Shinva Medical Subsidiary Secures Class III Medical Device Approvals

Stock News
Yesterday

Shinva Medical Instrument Co., Ltd. (600587.SH) has announced that its subsidiary, Shinva Surgical Instruments Co., Ltd., recently received the Medical Device Registration Certificates issued by China's National Medical Products Administration. The approved products include plasma surgical equipment and single-use powered linear cutting staplers with staple cartridges and their components.

Once the plasma surgical equipment officially reaches the market, it will create deep synergies and efficient integration with the company's existing medical endoscope camera systems and minimally invasive laparoscopic surgical instruments. This move not only achieves complementary advantages between equipment and consumable product lines but also expands the boundaries of the company's comprehensive minimally invasive surgery solutions, thereby strengthening its overall competitive position in the minimally invasive surgery sector.

The single-use powered linear cutting staplers with staple cartridges and components will work in coordination with the company's existing minimally invasive laparoscopic surgical instrument platform. With these two products now certified, the company has enriched its product portfolio in the minimally invasive laparoscopic surgery field, elevated its comprehensive competitive edge in minimally invasive surgery, and enhanced its market coverage capabilities and brand influence.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10